Brent Saunders returns as Bausch + Lomb CEO, board chair
Click Here to Manage Email Alerts
Brent Saunders has been appointed as CEO and chair of the board of directors at Bausch + Lomb, effective March 6, according to a company press release.
Joseph C. Papa will step down as CEO and director, and Thomas W. Ross Sr. will become the lead independent director of the board.
Image: Adobe Stock
On Feb. 16, Saunders will rejoin Bausch + Lomb in an advisory capacity alongside Papa to facilitate an orderly transition, according to the release.
“I am honored to once again lead Bausch + Lomb during this exciting time as a new publicly traded company,” Saunders said in the release. “I am confident in our future, and I look forward to once again working alongside the more than 12,000 employees who live by and aspire to achieve the Bausch + Lomb mission of helping people see better to live better.”
Saunders previously served as the company’s CEO from 2010 to 2013, until Valeant Pharmaceuticals, now Bausch Health, acquired Bausch + Lomb in 2013. He has served as president, CEO and chairman at other global pharmaceutical and health care companies such as Schering-Plough, Forest Laboratories, Actavis, Allergan and The Beauty Health Company.
“On behalf of all the employees of Bausch + Lomb, I also would like to recognize Joe Papa and thank him for all he has done to advance the health, safety and wellness of patients around the world,” Saunders said in the release.
Read more about
Click Here to Manage Email Alerts